awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33423168-98028D40-15C2-464C-9A7D-8869BD5D8AAA
Q33423168-98028D40-15C2-464C-9A7D-8869BD5D8AAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33423168-98028D40-15C2-464C-9A7D-8869BD5D8AAA
Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
P2860
Q33423168-98028D40-15C2-464C-9A7D-8869BD5D8AAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33423168-98028D40-15C2-464C-9A7D-8869BD5D8AAA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a465b6e16598ef832615c27f2996dbbbfd9ffa95
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.